Syndax Pharmaceuticals Inc (SNDX) Stock Price, Quote, News & History

SNDXNASDAQ
$20.56
-0.12-0.58%
Last update: Sep 4, 7:13 PM
$20.56
-0.12-0.58%

Syndax Pharmaceuticals (SNDX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-220.64M
Investing Cash Flow (TTM)
175.48M
Financing Cash Flow (TTM)
272.88M
Free Cash Flow (TTM)
-220.87M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
227.73M

Analyst Trends and Forecast

3
May
1
Jun
1
Jul
3
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.87B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
7.20
PB Ratio (TTM)
122.30
Earnings Yield % (TTM)
-12.14%
Earnings Yield % (FWD)
-1.98%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.17

Company Debt

Total Debt
$588.12M
LT Debt
$588.12M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$336.48M
Debt to Equity
39.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$20.46
Close
$20.56
Volume / Avg.
1.36M / 1.80M
Day Range
$20.46 - $21.00
52 Wk Range
12.99 - 25.59
Market Cap
$1.84B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
26.09%
Days to Cover
15.03

About

Sector
Health Care
Industry
Biotechnology
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Syndax Pharmaceuticals (SNDX) stock?

A

You can purchase shares of Syndax Pharmaceuticals (NASDAQ:SNDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Syndax Pharmaceuticals (SNDX) competitors?

Q

What is the forecast, or price target, for Syndax Pharmaceuticals (SNDX) stock?

A

Syndax Pharmaceuticals has a consensus price target of $37.60.

Q

What is the current price for Syndax Pharmaceuticals (SNDX)?

A

The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $20.56 last updated September 4, 2026 at 7:13 PM EDT.

Q

Does Syndax Pharmaceuticals (SNDX) pay a dividend?

A

There are no upcoming dividends for Syndax Pharmaceuticals.

Q

When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?

A

Syndax Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Syndax Pharmaceuticals (SNDX) going to split?

A

There is no upcoming split for Syndax Pharmaceuticals.

Q

What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?

A

Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.